Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Kappa opioid receptors as modulators of novelty processing

Neuropsychopharmacology volume 48, pages 848–849 (2023)Cite this article

Subjects

A Correction to this article was published on 03 May 2023

This article has been updated

A long-standing notion is that kappa opioid receptors (KOPR) are part of negative valence brain systems that contribute to anhedonia and aversive motivated behaviors. Overactivation of KOPR systems has been posited to play are role in drug withdrawal aversion and the motivation to alleviate drug withdrawal [1]. Additionally, KOPRs, like the other opioid receptors, also have analgesic effects. The combination of its low abuse potential (due to its presumed aversive effects), coupled with its therapeutic potential, has made KOPR an appealing target for pain management and addiction treatment. There are many studies corroborating the use of KOPR agonists and antagonists to improve negative affective states [2]. But there is also literature indicating that KOPR modulation can instead produce anxiety, increase drug intake, or have no effect [3]. Despite the expansive literature, until now the hypothesis that KOPRs selectively contribute to negative valence processing and behavioral responses to aversive stimuli had not been directly tested. In their article published in this issue of Neuropsychopharmacology, Farahbakhsh et al. have directly tested this theory using positive and negative reinforcement procedures [4].

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Change history

References

  1. Wee S, Koob GF. The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology. 2010;210:121–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bruchas MR, Land BB, Chavkin C. The Dynorphin-Kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010;1314C:44.

    Article  Google Scholar 

  3. Pirino BE, Spodnick MB, Gargiulo AT, Curtis GR, Barson JR, Karkhanis AN. Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis. Neuropharmacology. 2020;181:108341.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Farahbakhsh ZZ, Song K, Branthwaite HE, Erickson KR, Mukerjee S, Nolan SO, et al. Systemic kappa opioid receptor antagonism accelerates reinforcement learning via augmentation of novelty processing in male mice. Neuropsychopharmacology. 2023:1–12. https://www.nature.com/articles/s41386-023-01547-x.

  5. Lewis AS, Calipari ES, Siciliano CA. Toward standardized guidelines for investigating neural circuit control of behavior in animal research. ENeuro. 2021;8:1–6.

Download references

Funding

This work was funded by grant R00DA049862, the McDonnell Center for Cellular and Molecular Neurobiology, and the McDonnell Center for Systems Neuroscience.

Author information

Authors and Affiliations

  1. Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO, 63110, USA

    Kathryn Braden & Daniel C. Castro

Authors
  1. Kathryn Braden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel C. Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KB: Draft preparation and review; DCC: reviewing, editing, and preparation of final submission.

Corresponding author

Correspondence to Daniel C. Castro.

Ethics declarations

Competing interests

The authors declare that they have no competing interests or disclosures with this publication.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised due to a retrospective Open Access cancellation.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Braden, K., Castro, D.C. Kappa opioid receptors as modulators of novelty processing. Neuropsychopharmacol. 48, 848–849 (2023). https://doi.org/10.1038/s41386-023-01561-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41386-023-01561-z

Search

Advanced search

Quick links